Retatrutide lab tests

Seven checks before you trust a Retatrutide certificate

The same seven questions decide whether a certificate of analysis means anything, whichever compound it describes. Six are about the document; the seventh is about what no document can tell you.

1. An independent, batch-matched COA. The certificate must name the batch or lot in your hands, and must come from a laboratory the vendor neither owns nor pays. A specimen certificate from an earlier lot proves nothing about the vial you were sent.
2. HPLC purity, read against a known band. A purity figure is only informative against the distribution for that compound. "Above 98%" is not a claim — the useful question is whether the result sits inside the range the rest of the market reports. How to read HPLC and mass-spec results.
3. Mass-spectrometry identity. HPLC says how much of the sample is one thing; it does not say which thing. Only a mass-spec result establishes identity, and it is the only check that separates compounds a few daltons apart. Contamination is not hypothetical: research-grade custom peptides from two independent commercial suppliers were found to carry contaminating peptides at roughly 1% by weight, enough to produce false-positive results in immunology assays (Clinical and Vaccine Immunology, 2008 — a study of HIV vaccine peptide libraries rather than of any compound on this site).
4. Net content, measured rather than assumed. Purity and quantity are different questions: a vial can be 99.7% pure and still contain two thirds of the labelled mass. Why 10 mg isn't 10 mg.
5. Endotoxin (LAL) on the batch. An absent endotoxin line means the batch was not tested — not that it passed. Endotoxin testing and LAL interpretation.
6. Who ran the test, and what they left off. A laboratory with a record on this compound, named on the certificate, with a verification route back to it. Testing laboratories we track · Red flags in a certificate of analysis.
7. What no test on the vial can establish. A perfect certificate confirms that a vendor sold the correct molecule at the stated quantity. It says nothing about efficacy, dosing, or long-term safety.

Want a vial tested yourself? How to send a peptide for independent HPLC testing.

What retatrutide testing has to rule out

Retatrutide is a triple agonist at the GIP, GLP-1 and glucagon receptors: formula C₂₂₁H₃₄₂N₄₆O₆₈, molecular weight 4,731.0 g/mol, PubChem CID 172898051, development code LY3437943. That puts it 82 daltons below tirzepatide at 4,813.0. The two are acylated multi-agonist peptides of similar size, stocked by the same shops and frequently listed side by side with near-identical descriptions, so a mislabelled vial does not require anyone to have intended it. A mass spectrometer resolves the 82-dalton gap; an HPLC purity figure does not address it at all.

The CAS number commonly quoted for retatrutide, 2381089-83-2, could not be verified against a chemical registry, and PubChem's record does not expose a CAS for it. A vendor presenting that number as settled specification is signalling a spec sheet assembled from other vendors' spec sheets.

Across 1,150 independent tests on this platform (verified August 2026) retatrutide averaged 99.67%, with individual results running 99.52% to 99.98% — an unusually tight band, so a result outside it is informative in a way that "above 98%" never is. Quantity variance on record ran −4% to +22.5%, with most results within ±5%. LAL endotoxin results are rarely reported for retatrutide.

Piatkowski, Craven, Cornell & Ferris report on the composition and labelling accuracy of products sold as retatrutide in Australia (Drug and Alcohol Review, September 2026, DOI 10.1111/dar.70231). The citation was verified but the abstract could not be obtained, so its conclusions are not characterised here; it is the closest peer-reviewed analogue to what this platform does.

• Mass near 4,731.0 Da on a batch-matched certificate, not 4,813.0 (tirzepatide).
• HPLC purity inside the 99.52%–99.98% band recorded across 1,150 tests.
• Quantitative content testing: +22.5% over label is on record.
• The salt form stated on the certificate — it determines what a labelled 10 mg vial actually weighs.
• An LAL endotoxin result on the batch; it is rarely reported on this compound.